Knowing facts before you bet on it

Intuitive operation, Inc. (ISRG) has recently been one of the most sought stocks on Zacks.com. Perhaps you would like to see some of the facts that could affect the performance of the stock at short notice.

Last month, the shares of this company returned +14.6% compared to the change in the Zacks S&P 500 Composite +9.1%. During this time, the Zacks Medical instruments in which intuitive surgical speech falls, increased by 8.8%. The key question now is: What could be the future direction of the stock?

Although media reports or rumors about a significant change in the business prospects of a company generally lead to the fact that its shares lead to trend and an immediate change in price, there are always certain basic factors that ultimately advance the purchase and hate decision.

Instead of concentrating on anything else, we prioritize the evaluation of the change in the profit projection of a company at Zacks. This is due to the fact that we believe that the current value for its shares is determined by the cash value of his future profit current.

We essentially take a look at how analysts that cover the shares reveal their profit estimates in order to reflect the effects of the latest business trends. And if the profit estimates for a company rise, the current value for its shares increases. A higher atmosphere to be used than the current market price gives investors the interest for buying the share, which leads at a higher price. For this reason, empirical research shows a strong correlation between trends in the revisions of the yield estimate and short -term share price movements.

For the current quarter, intuitive surgery is expected to make a profit of $ 1.93 per share, which indicates a change of +8.4% compared to the previous year. The Zacks Consensus estimate has changed in the past 30 days by -1.4%.

For the current financial year, the consensus result estimate of $ 7.86 refers to a change of +7.1% compared to the previous year. In the past 30 days, this estimate has changed -2.7%.

For the next financial year, the consensus assessment of $ 9.10 shows a change of +15.9% compared to what intuitive surgery is expected a year ago. Last month the estimate changed -2.9%.

With an impressive external, tested success balance sheet is our proprietary stock assessment tool and the Zacks-rank-rank-a more cozy indicator for the short-term price-performance of a share, since it effectively uses the power of the profit assessment revisions. The size of the recent change in the consensus estimate and three other factors in connection with the profit estimates led to a Zacks rank 3 (Hold) for intuitive surgery.

The following table shows the development of the company's 12-month consensus EPS EPS estimate:

12-month consensus EPS estimate for ISRG _12monthepscharturl

Although the profit growth of a company is probably the best indicator of its financial health, not much happens if it cannot increase its income. It is almost impossible for a company to increase its income without increasing its sales over long periods of time. It is therefore crucial to know the potential sales growth of a company.

For intuitive surgery, consensus sales for the current quarter of $ 2.35 billion shows a change of +16.8%compared to the previous year. For the current and next financial years, estimates of USD 9.65 billion and 11.11 billion USD +15.6% or +15.1% make changes.

In the last quarter, intuitive surgery reported sales of $ 2.25 billion, which corresponds to a change of +19.2%compared to the previous year. EPS of USD 1.81 for the same period comparable to USD 1.50 a year ago.

Compared to the Zacks Consensus estimate of 2.18 billion US dollars, the registered income is a surprise of +3.27%. The EPS surprise was +5.85%.

The company defeated consensus -epseps estimates in each of the following four quarters. The company has achieved three times consensus sales estimates three times during this period.

No investment decision can be efficient without taking into account the evaluation of a share. Whether the current price of a share rightly reflects the internal value of the underlying business and the growth prospects of the company is an essential determinant for future price -performance.

The comparison of the current value of the valuation multipliers of a company, such as

The Zacks Value Style Score (part of the Zacks Style Scores Systems), which pays attention to the grade of stocks from A to F both traditional and unconventional valuation metrics (AA is better than a C; and so on) is rather helpful to identify whether a share is overrated, legally valued or temporarily accommodated.

Intuitive surgery is evaluated on this Front D, which indicates that she acts with a bonus with his colleagues. Click here to display the values of some evaluation metrics that have driven this grade.

The facts discussed here and a lot of other information about Zacks.com could help determine whether it is worth paying attention to the market for intuitive surgery or not. However, the Zacks ranked 3rd indicate that it is in line with the broader market at short notice.

Would you like the latest recommendations from Zack's Investment Research? Today you can download 7 best stocks for the next 30 days. Click here to receive this free report

Intuitive surgical, Inc. (ISRG): Report on free stock analysis

This article was originally published in Zack's Investment Research (Zacks.com).

Zacks Investment Research

Leave a Comment Cancel reply